NovoCure (NVCR) Q2 2026 Earnings

30AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.62
-0.52
-0.41
-0.31

Details

Expected EPS
-0.512186
Actual EPS
-0.62
Surprise EPS
-0.11
Surprise Percent
+21.05%

Description

NovoCure (NVCR) has reported earnings of -0.62 per share for Q2 2026.

0 Comments

Share your thoughts